ThymoSpheres culture: A model to study human polyclonal unconventional T cells
European Journal of Immunology · 2024
DOI: 10.1002/eji.202451265 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Lore Billiet und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, Stichting Tegen Kanker.
Abstract (Originalsprache)
In vitro cultures remain crucial for studying the fundamental mechanisms of human T‐cell development. Here, we introduce a novel in vitro cultivation system based on ThymoSpheres (TS): dense spheroids consisting of DLL4‐expressing stromal cells and human hematopoietic precursor cells, in the absence of thymic epithelial cells. These spheroids are subsequently cultured at the air–liquid interphase. TS generate large numbers of mature T cells, are easy to manipulate, scalable, and can be repeatably sampled to monitor T‐cell differentiation. The mature T cells generated from primary human hematopoietic precursor cells were extensively characterized using single‐cell RNA and combined T‐cell receptor (TCR) sequencing. These predominantly CD8α T cells exhibit transcriptional and TCR CDR3 characteristics similar to the recently described human polyclonal αβ unconventional T cell (UTC) lineage. This includes the expression of hallmark genes associated with agonist selection, such as IKZF2 (Helios), and the expression of various natural killer receptors. The TCR repertoire of these UTCs is polyclonal and enriched for CDR3‐associated autoreactive features and early rearrangements of the TCR‐α chain. In conclusion, TS cultures offer an intriguing platform to study the development of this human polyclonal UTC lineage and its inducing selection mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
- Department of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), Brussels, Belgium.
- Institute for Medical Immunology, Université Libre de Bruxelles (ULB), Brussels, Belgium.
- ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Brussels, Belgium.
- WELBIO Department, WEL Research Institute, Wavre, Belgium.
- Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
ORCID-Profile: Lore Billiet, Lena Boehme, Lucas Deseins, Jana Roels
Förderung
- Fonds Wetenschappelijk Onderzoek
- Stichting Tegen Kanker
Zitieren
APA
Billiet, L., Jansen, H., Pille, M., Boehme, L., Sanchez Sanchez, G., De Cock, L., Goetgeluk, G., Pascal, E., De Munter, S., Deseins, L., Ingels, J., Michiels, T., De Vos, R., Zolfaghari, A., Vandamme, N., Roels, J., Kerre, T., Dmitriev, R. I., Taghon, T., …, & Vandekerckhove, B. (2024). ThymoSpheres culture: A model to study human polyclonal unconventional T cells. European Journal of Immunology. https://doi.org/10.1002/eji.202451265
Vancouver
Billiet L, Jansen H, Pille M, Boehme L, Sanchez Sanchez G, De Cock L, et al. ThymoSpheres culture: A model to study human polyclonal unconventional T cells. European Journal of Immunology. 2024. doi:10.1002/eji.202451265
BibTeX
@article{Billiet2024,
author = {Billiet, Lore and Jansen, Hanne and Pille, Melissa and Boehme, Lena and Sanchez Sanchez, Guillem and De Cock, Laurenz and Goetgeluk, Glenn and Pascal, Eva and De Munter, Stijn and Deseins, Lucas and Ingels, Joline and Michiels, Thomas and De Vos, Robrecht and Zolfaghari, Amin and Vandamme, Niels and Roels, Jana and Kerre, Tessa and Dmitriev, Ruslan I and Taghon, Tom and Vermijlen, David and Vandekerckhove, Bart},
title = {ThymoSpheres culture: A model to study human polyclonal unconventional T cells},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202451265}
}
EUVIMED